Aaron Wealth Advisors LLC Buys 1,150 Shares of Intuitive Surgical, Inc. $ISRG

Aaron Wealth Advisors LLC lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 22.4% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 6,280 shares of the medical equipment provider’s stock after acquiring an additional 1,150 shares during the period. Aaron Wealth Advisors LLC’s holdings in Intuitive Surgical were worth $3,557,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in ISRG. Brighton Jones LLC lifted its holdings in shares of Intuitive Surgical by 24.9% during the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after acquiring an additional 731 shares during the last quarter. Sivia Capital Partners LLC lifted its holdings in shares of Intuitive Surgical by 3.8% during the 2nd quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock worth $504,000 after acquiring an additional 34 shares during the last quarter. Schnieders Capital Management LLC. lifted its holdings in shares of Intuitive Surgical by 38.0% during the 2nd quarter. Schnieders Capital Management LLC. now owns 973 shares of the medical equipment provider’s stock worth $529,000 after acquiring an additional 268 shares during the last quarter. StoneX Group Inc. lifted its holdings in shares of Intuitive Surgical by 9.6% during the 2nd quarter. StoneX Group Inc. now owns 1,054 shares of the medical equipment provider’s stock worth $573,000 after acquiring an additional 92 shares during the last quarter. Finally, Cary Street Partners Investment Advisory LLC lifted its holdings in shares of Intuitive Surgical by 20.4% during the 2nd quarter. Cary Street Partners Investment Advisory LLC now owns 472 shares of the medical equipment provider’s stock worth $256,000 after acquiring an additional 80 shares during the last quarter. 83.64% of the stock is owned by institutional investors.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 421 shares of the business’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total value of $208,378.16. Following the transaction, the executive vice president owned 409 shares in the company, valued at approximately $202,438.64. The trade was a 50.72% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Fredrik Widman sold 133 shares of the business’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total transaction of $65,829.68. Following the completion of the transaction, the vice president owned 660 shares in the company, valued at $326,673.60. The trade was a 16.77% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 32,943 shares of company stock valued at $17,279,568. Company insiders own 0.60% of the company’s stock.

Intuitive Surgical Trading Up 0.1%

ISRG stock opened at $452.58 on Tuesday. The firm’s 50-day moving average price is $485.91 and its two-hundred day moving average price is $514.33. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $603.88. The stock has a market capitalization of $160.72 billion, a price-to-earnings ratio of 57.36, a PEG ratio of 3.49 and a beta of 1.68.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The firm had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.72 billion. During the same quarter in the previous year, the company earned $2.21 earnings per share. The company’s revenue for the quarter was up 18.8% compared to the same quarter last year. Equities analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analysts Set New Price Targets

A number of research firms have recently issued reports on ISRG. The Goldman Sachs Group reaffirmed a “buy” rating and set a $714.00 price objective on shares of Intuitive Surgical in a report on Friday, January 9th. Wall Street Zen downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Saturday, February 7th. Robert W. Baird lowered their price target on shares of Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating for the company in a research note on Friday, January 23rd. BTIG Research reissued a “buy” rating and issued a $616.00 price target on shares of Intuitive Surgical in a research note on Friday, January 23rd. Finally, UBS Group lowered their price target on shares of Intuitive Surgical from $570.00 to $550.00 and set a “neutral” rating for the company in a research note on Tuesday, March 17th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus price target of $611.77.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.